Skip to content
value.today
Genprex, Inc. logo

Genprex, Inc.

🇺🇸 Austin, Texas, USABiotechnologyFounded 2009
Total raised
$11 M
2 rounds on record
Latest round
$10 M
May 2018
First round on record
Dec 2013
Today
Went public
See the company page

Genprex, Inc. is listed today as Genprex Inc.: market value, financials and filings are on its company page.

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Genprex, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2018$10 MNo. 2$10 to $50 million

Genprex, Inc.: Raise no. 2, May 2018

Investors in this round

2 investors had bought by the notice of May 23, 2018: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
$700,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Texas

People named in the notice

  • John Rodney Varner · Executive Officer, Director
  • Julien Rodney Pham · Executive Officer
  • Ryan Rodney Confer · Executive Officer
  • David Rodney Friedman · Director
  • Robert Rodney Pearson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Maxim Group LLC (CRD 120708) · New York, New YorkSold in NJ, NY

Remarks in the notice

  • On the use of proceeds: “Proceeds will be used for general working capital, which includes officer salaries. No proceeds will be paid directly to persons named in Item 3.”

Signed by Rodney Varner, Chief Executive Officer. Source: SEC Form D, newest notice filed May 23, 2018. Read the notice at the SEC.

equity, optionsSEC
Dec 2013$1 MNo. 1Under $2 million

Genprex, Inc.: Raise no. 1, Dec 2013

Investors in this round

1 investor had bought by the notice of Dec 30, 2013: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
$1,400,000
What was sold
equity
Exemption claimed
  • Rule 505: the former limited-offering exemption (withdrawn in 2017)
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
  • Section 4(a)(5): accredited investors only, up to $5 million, no public advertising
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
$50,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • John Rodney Varner · Executive Officer, Director
  • Bob Pearson · Director
  • David Friedman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Rodney Varner, Ceo. Source: SEC Form D, newest notice filed Dec 30, 2013. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Genprex, Inc. had no revenue when it filed its newest notice of a funding round (May 2018).

    SEC Form D (revenue range) · May 2018

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · May 2018

Products and services#

No products or services of Genprex, Inc. are on record.

Investors#

No investor of Genprex, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 2 investors.

Largest shareholders today

Institutions holding Genprex Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Genprex, Inc.
NameRoleNamed in
John Rodney VarnerExecutive officerMay 2018
Julien Rodney PhamExecutive officerMay 2018
Ryan Rodney ConferExecutive officerMay 2018
David Rodney FriedmanDirectorMay 2018
John Rodney VarnerDirectorMay 2018
Robert Rodney PearsonDirectorMay 2018
Bob PearsonDirectorDec 2013
David FriedmanDirectorDec 2013

Went public since 2018. Its SEC number is that of a company listed on a stock exchange.